-
Why Pfizer's Shares Are Slipping 7.6% Today
Post on 6/2/20
-
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
Post on 6/1/20
-
TapestryHealth Is The New Name Of Tapestry Telehealth
Post on 6/1/20
-
Pfizer Comes Up Empty In Ibrance Breast Cancer Study
Post on 6/1/20
-
Pfizer: Set Limit Orders No Higher Than $33.94
Post on 6/1/20
-
Merck's Keytruda Better Than Chemotherapy for Certain Colon Cancers
Post on 6/1/20
-
Is Pfizer a Great Dividend Stock?
Post on 6/1/20
-
Pfizer Breast Cancer Drug Posts "Disappointing" Results in Clinical Trials
Post on 6/1/20
-
Regeneron Completes Offering Of Sanofi-Held Stock
Post on 6/1/20
-
Caladrius Biosciences Closes $4.3M Registered Direct Offering
Post on 5/31/20
-
Fortress Biotech Prices Series A Preferred Stock Offering
Post on 5/31/20
-
Regeneron Completes Secondary Offering of Common Stock
Post on 5/31/20
-
Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress
Post on 5/29/20
-
Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate
Post on 5/29/20
-
Is Johnson and Johnson Stock a Buy?
Post on 5/29/20
-
3 Reasons Why Biohaven Pharmaceuticals' Stock Is Taking Off
Post on 5/29/20
-
Dr. Meghan Patel Joins Capital Health OB/GYN
Post on 5/28/20
-
CipherHealth Named "Best Overall Patient Engagement Company" in 2020 MedTech Breakthrough Awards
Post on 5/28/20
-
Ambra Health Named Best Healthcare Technology Solution at 2020 SIIA CODiE Awards
Post on 5/27/20
-
Hoth Therapeutics Closes Public Offering of Common Stock
Post on 5/27/20
-
Deerfield Commits Up to $130 Million to Commercialize Drug Discovery at University of Michigan
Post on 5/27/20
-
At Last, Merck Is Diving Into Coronavirus Vaccine and Antiviral Development
Post on 5/27/20
-
Is Axsome Therapeutics a Buy?
Post on 5/27/20
-
Regeneron Prices Secondary Offering of its Common Stock Held by Sanofi
Post on 5/26/20
-
States with the Best Health Infrastructure for Coronavirus – WalletHub Study
Post on 5/26/20
New York
